Related Experiment Videos
[Biological markers in renal cell carcinoma]
T Ebert1, R Ackermann, N H Bander
1Urologische Universitätsklinik Düsseldorf.
Der Urologe. Ausg. A
|March 1, 1990
Summary
Immunoassays utilizing monoclonal antibodies show promise for early renal cancer diagnosis. Measuring specific kidney-associated antigens and peptides could significantly improve detection and cure rates for kidney cancer.
Area of Science:
- Oncology
- Immunology
- Biochemistry